Wilfred J Radler, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4263 Highway 68, Ste C, Golden Valley, AZ 86413 Phone: 928-565-3939 Fax: 928-565-4111 |
News Archive
Senior Constable Huy Quach has been living a sordid double life that is shocking spectators as it unfolds. A 20 year old woman suffering from bipolar disorder in her victim impact statement presented to the County Court, accused the constable of exploiting her sexually and of using his public office to intimidate her.
Kensey Nash Corporation, a leading medical technology company that provides innovative solutions and technologies for a wide range of medical procedures, today reported the results for its three and six months ended December 31, 2009.
ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) today announced data from a Phase 1 clinical trial evaluating oral ridaforolimus, its investigational mTOR inhibitor, in combination with bevacizumab (Avastin®) in heavily pretreated patients with refractory metastatic solid tumors. The data were presented at the Joint Multidisciplinary Congress of the 15th annual European Cancer Organization (ECCO) and the 34th annual European Society of Medical Oncology (ESMO) taking place in Berlin, Germany.
Experts at the European Society of Clinical Microbiology and Infectious Diseases – an organization promoting research, risk assessment, knowledge sharing and best practices in the fight against infectious diseases – are developing tools to monitor the spread of the Zika virus and are conducting research to gather more solid data to better assess the risks associated with the infection.
Using lipidomics, a technique that measures the composition of blood lipids at a molecular level, and machine learning, researchers at Lund University in Sweden have identified a blood lipid profile that improves the possibility to assess, several years in advance, the risk of developing type 2 diabetes.
› Verified 5 days ago